Resumen

BARRANCO-LAMPON, Gilberto; TUNA-AGUILAR, Elena  y  HURTADO-MONROY, Rafael. Chronic leukemias and SARS-CoV-2. Gac. Méd. Méx [online]. 2021, vol.157, suppl.3, pp.S42-S46.  Epub 25-Abr-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000469.

On January 30 of the 2020 year, the World Health Organization declared an international public health emergency the pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially, many doubts arose regarding treatment adjustments and follow-up of patients with chronic leukemias, and various international associations issued recommendations. The use of telemedicine and the selection of treatment strategies that allow care without patients going to hospital centers, has been one of the main techniques for protecting patients with chronic leukemias. International experience describes that it seems that patients with chronic myeloid leukemia are less susceptible to infection and death, unlike patients with chronic lymphocytic leukemia.

Palabras llave : Chronic myeloid leukemia; Chronic lymphocytic leukemia; Coronavirus; SARS-CoV-2.